The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment

Ségolène Hescot; Angelo Paci; Atmane Seck; Abdelhamid Slama; Say Viengchareun; Séverine Trabado; Sylvie Brailly-Tabard; Abir Al Ghuzlan; Jacques Young; Eric Baudin; Marc Lombès

doi:10.1007/s12672-014-0189-7

The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment

By Ségolène Hescot, Angelo Paci, Atmane Seck, Abdelhamid Slama, Say Viengchareun, Séverine Trabado, Sylvie Brailly-Tabard, Abir Al Ghuzlan, Jacques Young, Eric Baudin and Marc Lombès

Publisher: Springer Science and Business Media LLC

Year: 2014

DOI identifier: 10.1007/s12672-014-0189-7

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://www.ncbi.nlm.nih.gov/p... (external link)

http://link.springer.com/conte... (external link)

The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment

Suggested articles